Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever	Bunyaviridae infectious disease, Crimean-Congo hemorrhagic fever, Infections, RNA Virus Infections, arbovirus infection, tick-borne infectious disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease	Recruiting	Phase 1	2025-07-28		NCT06799013

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BioAgilytix Labs, LLC	1
Clinical Trials of Texas, Inc.	1
DFNet Research Inc.	2
HDT Bio	1
Quest Laboratories	1
Technical Resources International, Inc.	4
The University of Texas Medical Branch, Galveston	59

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Flourish Research San Antonio (Clinical Trials of Texas)	San Antonio	United States	1